Cargando…

Combined assay of Circulating Tumor DNA and Protein Biomarkers for early noninvasive detection and prognosis of Non-Small Cell Lung Cancer

Purpose: Early diagnosis of lung cancer is critical to curtailing cancer-related deaths. We aimed to develop a highly sensitive assay for the analysis of circulating tumor DNA (ctDNA) to detect non-small cell lung cancer (NSCLC) in the early stages. Materials and Methods: We detected EGFR and KRAS m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yin, Jian-xin, Hu, Wen-wei, Gu, Hua, Fang, Jian-min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797658/ https://www.ncbi.nlm.nih.gov/pubmed/33442424 http://dx.doi.org/10.7150/jca.49647

Ejemplares similares

Downregulated circulating microRNAs after surgery: potential noninvasive biomarkers for diagnosis and prognosis of early breast cancer
por: Wang, Yaohui, et al.
Publicado: (2018)

Detection of Methylated Circulating DNA as Noninvasive Biomarkers for Breast Cancer Diagnosis
por: Cheuk, Isabella Wai Yin, et al.
Publicado: (2017)

Circulating tumor DNA: a noninvasive biomarker for tracking ovarian cancer
por: Yang, Fang, et al.
Publicado: (2021)

Circulating miRNAs as Noninvasive Biomarkers for PDAC Diagnosis and Prognosis in Mexico
por: Álvarez-Hilario, Lissuly Guadalupe, et al.
Publicado: (2023)

Small Cell Size Circulating Aneuploid Cells as a Biomarker of Prognosis in Resectable Non-Small Cell Lung Cancer
por: Hong, Yang, et al.
Publicado: (2021)

Identification of circulating microRNA signatures as potential noninvasive biomarkers for prediction and prognosis of lymph node metastasis in gastric cancer
por: Jiang, Xiumei, et al.
Publicado: (2017)

DNA hypomethylation of CBS promoter induced by folate deficiency is a potential noninvasive circulating biomarker for colorectal adenocarcinomas
por: Xue, Geng, et al.
Publicado: (2017)

Post surgery circulating free tumor DNA is a predictive biomarker for relapse of lung cancer
por: Hu, Wenwei, et al.
Publicado: (2017)

A circulating microRNA signature as noninvasive diagnostic and prognostic biomarkers for nonalcoholic steatohepatitis
por: Liu, Jie, et al.
Publicado: (2018)

Midkine is a serum and urinary biomarker for the detection and prognosis of non-small cell lung cancer
por: Xia, Xin, et al.
Publicado: (2016)

Integrating Circulating Immunological and Sputum Biomarkers for the Early Detection of Lung Cancer
por: Su, Jian, et al.
Publicado: (2018)

Circulating Bacterial DNA as Plasma Biomarkers for Lung Cancer Early Detection
por: Zhou, Huifen, et al.
Publicado: (2023)

Noninvasive monitoring of the genetic evolution of EGFR-mutant non-small-cell lung cancer by analyzing circulating tumor DNA during combination chemotherapy with gefitinib and pemetrexed or S-1
por: Nakahara, Yoshiro, et al.
Publicado: (2016)

Circulating exosomal gastric cancer-associated long noncoding RNA1 as a noninvasive biomarker for predicting chemotherapy response and prognosis of advanced gastric cancer: A multi-cohort, multi-phase study
por: Song, Qiying, et al.
Publicado: (2022)

Circulating Tumor DNA as a Prognostic Biomarker in Localized Non-small Cell Lung Cancer
por: Peng, Muyun, et al.
Publicado: (2020)

MicroRNA Derived from Circulating Exosomes as Noninvasive Biomarkers for Diagnosing Renal Cell Carcinoma
por: Xiao, Chu-Tian, et al.
Publicado: (2020)

Circulating and tissue biomarkers in early-stage non-small cell lung cancer
por: Fumagalli, Caterina, et al.
Publicado: (2017)

Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer
por: Tang, Yong, et al.
Publicado: (2017)

Serum microRNA-210 as a potential noninvasive biomarker for the diagnosis and prognosis of glioma
por: Lai, N-s, et al.
Publicado: (2015)

A noninvasive multi-analyte diagnostic assay: combining protein and DNA markers to stratify bladder cancer patients
por: Fernandez, Cecilia A, et al.
Publicado: (2012)

(23)Na‐MRI as a Noninvasive Biomarker for Cancer Diagnosis and Prognosis
por: Poku, Linda Osei, et al.
Publicado: (2020)

Application of Circulating Tumor DNA as a Biomarker for Non-Small Cell Lung Cancer
por: Yang, Jialiang, et al.
Publicado: (2021)

Identification of Circulating Tumor DNA for the Early Detection of Small-cell Lung Cancer
por: Fernandez-Cuesta, Lynnette, et al.
Publicado: (2016)

Translation of a tissue epigenetic signature to circulating free DNA suggests BCAT1 as a potential noninvasive diagnostic biomarker for lung cancer
por: Palanca-Ballester, Cora, et al.
Publicado: (2022)

Accurate detection of early-stage lung cancer using a panel of circulating cell-free DNA methylation biomarkers
por: Hu, Shuo, et al.
Publicado: (2023)

Combined serum biomarkers in the noninvasive diagnosis of complicated parapneumonic effusions and empyema
por: Wu, Kuo-An, et al.
Publicado: (2019)

Smoking status combined with tumor mutational burden as a prognosis predictor for combination immune checkpoint inhibitor therapy in non‐small cell lung cancer
por: Sun, Li‐Yue, et al.
Publicado: (2021)

Serum miR-1228-3p and miR-181a-5p as Noninvasive Biomarkers for Non-Small Cell Lung Cancer Diagnosis and Prognosis
por: Xue, Wei-Xiao, et al.
Publicado: (2020)

Circulating metabolites as potential biomarkers for the early detection and prognosis surveillance of gastrointestinal cancers
por: Song, Guodong, et al.
Publicado: (2023)

Plasma hepatocyte growth factor as a noninvasive biomarker in small cell lung cancer
por: Zhao, Cong, et al.
Publicado: (2023)

DNA Methylation as a Noninvasive Epigenetic Biomarker for the Detection of Cancer
por: Leygo, Catherine, et al.
Publicado: (2017)

5-Hydroxymethylome in Circulating Cell-free DNA as A Potential Biomarker for Non-small-cell Lung Cancer
por: Zhang, Ji, et al.
Publicado: (2018)

Methylated circulating tumor DNA as a biomarker for colorectal cancer diagnosis, prognosis, and prediction
por: Nassar, Farah J., et al.
Publicado: (2021)

Circulating Tumor DNA Predicts the Response and Prognosis in Patients With Early Breast Cancer Receiving Neoadjuvant Chemotherapy
por: Li, Shunying, et al.
Publicado: (2020)

Multidimensional Cell-Free DNA Fragmentomic Assay for Detection of Early-Stage Lung Cancer
por: Wang, Siwei, et al.
Publicado: (2022)

Circulating Methylated XAF1 DNA Indicates Poor Prognosis for Gastric Cancer
por: Ling, Zhi-Qiang, et al.
Publicado: (2013)

Circulating mitochondrial DNA levels are associated with early diagnosis and prognosis in patients with sepsis
por: Zhou, Gaosheng, et al.
Publicado: (2022)

Optimized combination of circulating biomarkers as predictors of prognosis in AECOPD patients complicated with Heart Failure
por: Yao, Can, et al.
Publicado: (2021)

Combined detection of dickkopf-1 subtype classification autoantibodies as biomarkers for the diagnosis and prognosis of non-small cell lung cancer
por: Shen, Lei, et al.
Publicado: (2017)

Early Noninvasive Metabolic Biomarkers of Mutant IDH Inhibition in Glioma
por: Radoul, Marina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7k68nlbfe9spu8bfqvr6p0s12i